Melbourne biosciences company Esfam Biotech says it is on track to commence human trials for a COVID-19 treatment by the end of 2021.
Technology is helping to improve the way cardiovascular disease (CVD) - currently the leading cause of death globally - can be detected, monitored and treated, according to a new research report.
Good ad concise overview!
Daldry's B Corp certification is neither the first nor the only such certification in Australia. This fact is readily verified,[…]
.....But there not reliable..and they wherever will beWe keep saying it should be treated like water, but if you don't[…]
Thx Ken!It would be excellent to get a followup article in the interest of journalistic insight,specifically on the actual trending[…]
With so many jobs in the IT sector, I'm pretty sure that if someone wanted a job they'd have one,[…]